Results per Page:
Turns out, HSV antivirals are (and aren’t) skin-deep
From The Zhu Lab, Vaccine and Infectious Disease Division
BRCA1/2: Why men should be screened for the “breast cancer gene”
New research shows that men can carry mutations in the BRCA1 and BRCA2 genes that increase their risk of several cancers, but new national guidelines are helping to educate patients
10 Washington groups take on cancer health disparities with grants from Fred Hutch
Community Grants Program funds projects statewide to improve cancer outcomes and build organizational capacity
Fred Hutch to lead new federal Cancer Screening Research Network
Clinical trials will evaluate emerging technologies that screen for cancer
Finding the golden ticket? Cyclin T1 is required for HIV-1 latency reactivation
From the Emerman lab, Human Biology and Basic Sciences Divisions
International symposium focuses on lobular breast cancer
Clinicians, researchers and patients from around the world gather in Pittsburgh to honor Seattle advocate, discuss understudied disease
The Beam: August proton therapy highlights including what cancers affect Asian men, summer hydration tips, and a staff profile
Which cancers affect Asian men; quarterly nutrition column with hydration recipes; dosimetrist Christine Oh.
A pseudovirus system to fight viral antibody escape
From the Bloom Lab, Basic Sciences and Public Health Sciences Divisions
Hopes and predictions for 2022
Hutch researchers look ahead to an increase in cancer screening, improved vaccines and greater trust in science
Catching up with cancer as COVID-19 starts to ebb
Public health researchers scramble to get preventive cancer screenings back on peoples’ radar – and calendars – as cases dwindle and restrictions lift
Prostate cancer researcher Dr. Janet Stanford retires after three decades
Career of discoveries about prostate cancer genetics, risks, outcomes
In Uganda: Treating twin threats of HIV and cancer
Dr. Sue Desmond-Hellmann of the Bill & Melinda Gates Foundation visits Hutch researchers in Kampala
What's new in prostate cancer: 5 takeaways
‘Many reasons for optimism’ says expert at annual community symposium
Fred Hutch, SCCA receive CEO Cancer Gold Standard accreditation for their ongoing commitment to employee health
Recognition of employers' efforts to reduce chronic disease risk in workforce
Matching up cancer risk with reality
New examination of prostate cancer data identifies ‘detection bias’ in prostate studies